Skip to main content

Table 2 Nucleotide variations in HPV16As LCRs from HSIL and SCC samples compared with the HPV16 LCR reference sequence [GenBank:AY686584]

From: Association of human papillomavirus type 16 long control region mutation and cervical cancer

 

HPV16 LCR

Number of samples (%) (n=43)

 

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

32

33

34

35

36

37

38

 

Binding site

    

TEF-1

            

GRE-1

GRE-1

    

YY-1

  

YY-1

 

YY-1, SP-1, OCT-1

 

E2BS-3

   

SP-1

SP-1, E2BS-2

E2BS-1

  

% of samples

100

100

7

2.3

100

100

2.3

2.3

4.7

95.3

100

95.3

4.7

2.3

2.3

41.9

4.7

2.3

2.3

100

2.3

2.3

100

9.3

2.3

2.3

2.3

2.3

100

2.3

2.3

39.5

2.3

100

4.7

4.7

4.7

100

 

Changed position

7175

7177

7179

7186

7193

7201

7213

7217

* 7218

7270

7287

7289

* 7384

7405

7418

* 7429

* 7430

7485

7489

7521

* 7617

7623

7730

7781

7791

7792

7802

7813

7842

* 7844

7868

* 7874

7886

24

* 28

* 46

* 61

81

 

HPV16 pt.

A

T

G

T

G

T

G

G

T

C

A

A

T

T

T

G

C

A

G

G

C

G

A

T

T

C

C

T

G

A

G

C

C

C

G

T

T

G

 

HPV16 As

C

C

-

-

T

C

-

-

-

-

C

-

-

-

-

-

-

-

-

A

-

-

C

-

-

-

-

-

A/T

-

-

-

-

T

-

-

-

-

 

SCC

                                       

As

C

C

-

-

T

C

-

-

-

T

C

C

-

-

-

-

-

-

-

A

-

-

C

-

-

-

-

-

A

-

-

-

-

T

-

-

-

T

8 (18.6%)

As-sv1

C

C

-

-

T

C

-

-

-

T

C

C

-

-

-

A

-

-

-

A

-

-

C

-

-

-

-

-

A

-

-

G

-

T

-

-

-

T

4 (9.3%)

As-sv2

C

C

-

G

T

C

-

-

-

T

C

C

-

-

-

-

-

-

-

A

-

-

C

C

-

T

-

-

T

-

-

-

-

T

-

-

-

T

1 (2.3%)

As-sv3

C

C

-

-

T

C

-

A

-

T

C

C

-

-

-

-

-

-

-

A

-

C^

C

-

-

-

-

-

A

-

-

-

-

T

-

-

-

T

1 (2.3%)

As-sv4

C

C

-

-

T

C

-

-

A

T

C

-

-

-

-

-

-

-

-

A

-

-

C

-

-

-

-

-

A

-

-

-

-

T

-

-

-

T

1 (2.3%)

As-sv5

C

C

-

-

T

C

-

-

-

T

C

T

G

-

-

-

T

-

-

A

-

-

C

-

-

-

-

-

A

-

-

-

-

T

-

-

-

T

1 (2.3%)

As-sv6

C

C

-

-

T

C

-

-

-

T

C

T

G

-

-

-

T

-

-

A

-

-

C

-

-

-

A

-

A

-

-

-

-

T

-

-

-

T

1 (2.3%)

As-sv7

C

C

-

-

T

C

-

-

-

T

C

-

-

G

-

-

-

-

-

A

-

-

C

-

-

-

-

-

A

-

-

-

-

T

-

-

-

T

1 (2.3%)

As-sv8

C

C

-

-

T

C

-

-

-

T

C

C

-

-

A

A

-

-

-

A

A^

-

C

-

-

-

-

-

A

-

-

G

-

T

-

-

-

T

1 (2.3%)

As-sv9

C

C

-

-

T

C

-

-

-

T

C

C

-

-

-

-

-

-

-

A

-

-

C

C

-

-

-

-

A

-

-

-

-

T

-

-

-

T

1 (2.3%)

As-sv10

C

C

-

-

T

C

-

-

-

T

C

C

-

-

-

-

-

-

-

A

-

-

C

C

-

-

-

-

T

C

-

-

-

T

-

-

-

T

1 (2.3%)

As-sv11

C

C

-

-

T

C

-

-

-

T

C

C

-

-

-

-

-

-

-

A

-

-

C

C

-

-

-

-

A

-

-

G

-

T

-

-

-

T

1 (2.3%)

As-sv12

C

C

-

-

T

C

-

-

-

-

C

C

-

-

-

-

-

C

A

A

-

-

C

-

-

-

-

-

A

-

-

-

-

T

-

-

-

T

1 (2.3%)

As-sv13

C

C

-

-

T

C

-

-

-

T

C

C

-

-

-

A

-

-

-

A

-

-

C

-

-

-

-

-

A

-

-

G

-

T

-

G^

-

T

1 (2.3%)

As-sv14

C

C

-

-

T

C

-

-

-

T

C

C

-

-

-

-

-

-

-

A

-

-

C

-

-

-

-

-

A

-

-

G

-

T

A^

G^

G^

T

1 (2.3%)

As-sv15

C

C

-

-

T

C

-

-

-

T

C

C

-

-

-

-

-

-

-

A

-

-

C

-

-

-

-

-

A

-

-

-

-

T

A^

-

G^

T

1 (2.3%)

As-sv16

C

C

-

-

T

C

-

-

-

T

C

C

-

-

-

A

-

-

-

A

-

-

C

-

del

-

-

G^

A

-

-

-

-

T

-

-

-

T

1 (2.3%)

HSIL

                                       

As-sv1

C

C

-

-

T

C

-

-

-

T

C

C

-

-

-

A

-

-

-

A

-

-

C

-

-

-

-

-

A

-

-

G

-

T

-

-

-

T

8 (18.6%)

As-sv17

C

C

T

-

T

C

-

-

-

T

C

C

-

-

-

A

-

-

-

A

-

-

C

-

-

-

-

-

A

-

-

-

-

T

-

-

-

T

2 (4.7%)

As-sv18

C

C

-

-

T

C

-

-

-

T

C

C

-

-

-

A

-

-

-

A

-

-

C

-

-

-

-

-

A

-

-

-

-

T

-

-

-

T

2 (4.7%)

As-sv19

C

C

T

-

T

C

C^

-

-

T

C

C

-

-

-

-

-

-

-

A

-

-

C

-

-

-

-

-

A

-

-

G

-

T

-

-

-

T

1 (2.3%)

As-sv20

C

C

-

-

T

C

-

-

A

-

C

C

-

-

-

A

-

-

-

A

-

-

C

-

-

-

-

-

A

-

-

-

-

T

-

-

-

T

1 (2.3%)

As-sv21

C

C

-

-

T

C

-

-

-

T

C

C

-

-

-

A

-

-

-

A

-

-

C

-

-

-

-

-

A

-

A

G

-

T

-

-

-

T

1 (2.3%)

As-sv22

C

C

-

-

T

C

-

-

-

T

C

C

-

-

-

A

-

-

-

A

-

-

C

-

-

-

-

-

A

-

-

G

A

T

-

-

-

T

1 (2.3%)

  1. *Novel nucleotide sequence variation found in this study, HPV16pt. = HPV16 prototype [GenBank:AY686584], As = HPV16As, As-sv = HPV16As sub-variant, TEF-1 = transcription factor binding site, GRE-1 = glucocorticoid response element, YY-1 = yin yang factor, SP-1 = trans-acting transcription factor, Oct-1 = octamer binding transcription factor, E2BS = E2 binding site.